<VariationArchive RecordType="classified" VariationID="126403" VariationName="Single allele" VariationType="Deletion" Accession="VCV000126403" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2015-03-24" MostRecentSubmission="2015-03-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="131936" VariationID="126403">
      <GeneList>
        <Gene Symbol="SAMHD1" FullName="SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1" GeneID="25939" HGNC_ID="HGNC:15925" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>20q11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="36889773" stop="36951708" display_start="36889773" display_stop="36951708" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="35520226" stop="35580245" display_start="35520226" display_stop="35580245" Strand="-" />
          </Location>
          <OMIM>606754</OMIM>
        </Gene>
      </GeneList>
      <Name>Single allele</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>20q11.2</CytogeneticLocation>
      </Location>
      <Comment DataSource="NCBI curation" Type="GenomicLocationNotEstablished">This deletion was defined by the failure of amplification of exons 12-16. The breakpoints in the genome were not determined. (Ramesh et al., 2010, PubMed 20653736)/</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="Single allele AND Aicardi-Goutieres syndrome 5" Accession="RCV000114344" Version="2">
        <ClassifiedConditionList TraitSetID="1109">
          <ClassifiedCondition DB="MedGen" ID="C2749659">Aicardi-Goutieres syndrome 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2014-03-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2014-03-13" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-03-24" MostRecentSubmission="2015-03-24">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301648</ID>
          <ID Source="BookShelf">NBK1475</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1109" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6631" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Aicardi-Goutieres syndrome 5</ElementValue>
                <XRef ID="MONDO:0013059" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AGS5</ElementValue>
                <XRef Type="MIM" ID="612952" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Most characteristically, Aicardi-Gouti√®res syndrome (AGS) manifests as an early-onset encephalopathy that usually, but not always, results in severe intellectual and physical disability. A subgroup of infants with AGS present at birth with abnormal neurologic findings, hepatosplenomegaly, elevated liver enzymes, and thrombocytopenia, a picture highly suggestive of congenital infection. Otherwise, most affected infants present at variable times after the first few weeks of life, frequently after a period of apparently normal development. Typically, they demonstrate the subacute onset of a severe encephalopathy characterized by extreme irritability, intermittent sterile pyrexias, loss of skills, and slowing of head growth. Over time, as many as 40% develop chilblain skin lesions on the fingers, toes, and ears. It is becoming apparent that atypical, sometimes milder, cases of AGS exist, and thus the true extent of the phenotype associated with pathogenic variants in the AGS-related genes is not yet known.</Attribute>
                <XRef ID="NBK1475" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10151" />
                <XRef ID="10151" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301648</ID>
                <ID Source="BookShelf">NBK1475</ID>
              </Citation>
              <XRef ID="51" DB="Orphanet" />
              <XRef ID="C2749659" DB="MedGen" />
              <XRef ID="MONDO:0013059" DB="MONDO" />
              <XRef Type="MIM" ID="612952" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="267538" SubmissionDate="2014-03-13" DateLastUpdated="2015-03-24" DateCreated="2014-04-19">
        <ClinVarSubmissionID localKey="NM_015474.3:c.(Exons 12-16del)|OMIM:612952" />
        <ClinVarAccession Accession="SCV000147920" DateUpdated="2015-03-24" DateCreated="2014-04-19" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-03-13">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SAMHD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015474.3:c.(Exons 12-16del)</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Aicardi Goutieres syndrome 5</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="612952" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GRs_3-13-14</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="267538" TraitType="Disease" MappingType="Name" MappingValue="Aicardi Goutieres syndrome 5" MappingRef="Preferred">
        <MedGen CUI="C2749659" Name="Aicardi-Goutieres syndrome 5" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

